2019
DOI: 10.1016/j.xphs.2019.02.023
|View full text |Cite
|
Sign up to set email alerts
|

Identification of IgG1 Aggregation Initiation Region by Hydrogen Deuterium Mass Spectrometry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1

Relationship

4
5

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 33 publications
0
8
0
Order By: Relevance
“…Mass spectrometry-based methods have been widely used for characterizing biopharmaceuticals. 21,22,23 Also in AAV, mass spectrometry methods have been recently applied for structural analysis of VPs. Intact mass spectrometry (intact MS) measurement combined with peptide mapping results revealed that the N-terminal methionine residue was cleaved and the next alanine residue was acetylated in VP1 and VP3, whereas there was no acetylation in VP2 for multiple AAV serotypes (AAV1, AAV2, AAV5, AAV7, AAV9, and AAVrh10).…”
Section: Introductionmentioning
confidence: 99%
“…Mass spectrometry-based methods have been widely used for characterizing biopharmaceuticals. 21,22,23 Also in AAV, mass spectrometry methods have been recently applied for structural analysis of VPs. Intact mass spectrometry (intact MS) measurement combined with peptide mapping results revealed that the N-terminal methionine residue was cleaved and the next alanine residue was acetylated in VP1 and VP3, whereas there was no acetylation in VP2 for multiple AAV serotypes (AAV1, AAV2, AAV5, AAV7, AAV9, and AAVrh10).…”
Section: Introductionmentioning
confidence: 99%
“…Binding regions between antibodies could be predicted by computational calculation 7 or directly investigated by hydrogen deuterium exchange mass spectrometry (HDX-MS). 8,9 However, it is still challenging to select amino acid residues to be replaced on an mAb sequence because even a single residue replacement impacts the physical properties of mAbs. 10 At the manufacturing and quality control stages, in addition to optimization of culture condition and purification process, a formulation development for mAbs has been attempted.…”
Section: Introductionmentioning
confidence: 99%
“…For the induced-fit model, a little low cooperativity may be allowed only when the variable domains remain their fold enough to recognize antigen upon losing interdomain stability. According to the previous DSC analyses using intact IgGs, T m values derived from Fab domain for intact rituximab, adalimumab and pertuzumab are available to be 76 °C, 70 °C and 77 °C, respectively (15; 29; 23). Of the three antibodies, only pertuzumab scFv showed a single peak transition in DSC analysis, and the T m 2 is 69.7 °C, which differs by approximately 7 °C.…”
Section: Discussionmentioning
confidence: 99%